450 related articles for article (PubMed ID: 19638467)
1. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Schweer K; Kailayangiri S; Campana D; Juergens H; Pule M; Rossig C
Clin Cancer Res; 2009 Aug; 15(15):4857-66. PubMed ID: 19638467
[TBL] [Abstract][Full Text] [Related]
2. 2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Juergens H; Pule M; Rossig C
Cancer Immunol Immunother; 2009 Dec; 58(12):1991-2001. PubMed ID: 19360406
[TBL] [Abstract][Full Text] [Related]
3. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
Chuang SS; Kumaresan PR; Mathew PA
J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
[TBL] [Abstract][Full Text] [Related]
4. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
[TBL] [Abstract][Full Text] [Related]
5. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
6. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
Messmer B; Eissmann P; Stark S; Watzl C
J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
[TBL] [Abstract][Full Text] [Related]
7. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
[TBL] [Abstract][Full Text] [Related]
8. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
9. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.
Suerth JD; Morgan MA; Kloess S; Heckl D; Neudörfl C; Falk CS; Koehl U; Schambach A
J Mol Med (Berl); 2016 Jan; 94(1):83-93. PubMed ID: 26300042
[TBL] [Abstract][Full Text] [Related]
10. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
[TBL] [Abstract][Full Text] [Related]
11. Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.
Jost S; Reardon J; Peterson E; Poole D; Bosch R; Alter G; Altfeld M
Immunology; 2011 Apr; 132(4):516-26. PubMed ID: 21214542
[TBL] [Abstract][Full Text] [Related]
12. Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function.
Vacca P; Pietra G; Falco M; Romeo E; Bottino C; Bellora F; Prefumo F; Fulcheri E; Venturini PL; Costa M; Moretta A; Moretta L; Mingari MC
Blood; 2006 Dec; 108(13):4078-85. PubMed ID: 16931625
[TBL] [Abstract][Full Text] [Related]
13. 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.
Xu Y; Liu Q; Zhong M; Wang Z; Chen Z; Zhang Y; Xing H; Tian Z; Tang K; Liao X; Rao Q; Wang M; Wang J
J Hematol Oncol; 2019 May; 12(1):49. PubMed ID: 31097020
[TBL] [Abstract][Full Text] [Related]
14. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice.
Johnson LA; Vaidya SV; Goldfarb RH; Mathew PA
Anticancer Res; 2003; 23(5A):3651-5. PubMed ID: 14666660
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation.
Sandusky MM; Messmer B; Watzl C
Eur J Immunol; 2006 Dec; 36(12):3268-76. PubMed ID: 17111350
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
[TBL] [Abstract][Full Text] [Related]
17. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).
Watzl C; Stebbins CC; Long EO
J Immunol; 2000 Oct; 165(7):3545-8. PubMed ID: 11034353
[TBL] [Abstract][Full Text] [Related]
18. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein.
Margraf-Schönfeld S; Böhm C; Watzl C
J Biol Chem; 2011 Jul; 286(27):24142-9. PubMed ID: 21606496
[TBL] [Abstract][Full Text] [Related]
20. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
Watzl C; Claus M
Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
